Literature DB >> 2757895

Effects of alpha-interferon on theophylline pharmacokinetics and metabolism.

J H Jonkman1, K G Nicholson, P R Farrow, M Eckert, G Grasmeijer, B Oosterhuis, O E De Noord, T W Guentert.   

Abstract

1. The influence of alpha-interferon (Roferon-A) on the pharmacokinetics and metabolism of theophylline was studied in healthy adults. Roferon-A was administered as an intra-muscular injection (3 x 10(6) iu) once-a-day over 3 days. One week prior to and immediately after this course a single 20 min aminophylline infusion (4 mg kg-1) was given. 2. Blood samples for theophylline analysis were taken over 48 h. Urine was collected up to 72 h and assayed for theophylline and its major metabolites 3-methylxanthine, 1,3-dimethyluric acid and 1-methyluric acid. 3. Pharmacokinetic parameters for theophylline in plasma were calculated. From urinary excretion data the overall metabolic clearance of theophylline and clearances for formation of the metabolites were calculated. 4. After interferon administration, there was a significant increase of approximately 15% in the mean values of the terminal elimination half-life, area under the curve and mean residence time of theophylline in association with a similar decrease in plasma clearance (P less than 0.05). Formation clearances of the metabolites tended to be smaller after treatment, but only the change in the overall clearance of theophylline was significantly different (P less than 0.05). There was no systematic shift in the metabolic pattern of theophylline. 5. Additional investigations of the influence of the duration of alpha-interferon treatment are necessary before definite conclusions can be drawn about the mechanism and the clinical relevance of the described interaction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757895      PMCID: PMC1379807          DOI: 10.1111/j.1365-2125.1989.tb03442.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  27 in total

1.  A study of the metabolism of theobromine, theophylline, and caffeine in man.

Authors:  H H CORNISH; A A CHRISTMAN
Journal:  J Biol Chem       Date:  1957-09       Impact factor: 5.157

2.  Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.

Authors:  M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

3.  Theophylline pharmacokinetics during respiratory viral infection.

Authors:  C J Clark; G Boyd
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

4.  Measurement of excretion characteristics of theophylline and its major metabolites.

Authors:  J H Jonkman; D Tang; R A Upton; S Riegelman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

Authors:  S Riegelman; P Collier
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

6.  Simultaneous determinations by theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography.

Authors:  K T Muir; J H Jonkman; D S Tang; M Kunitani; S Riegelman
Journal:  J Chromatogr       Date:  1980-11-14

7.  Theophylline metabolism by the rat liver microsomal system.

Authors:  S M Lohmann; R P Miech
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

8.  Effects of allopurinol on theophylline metabolism and clearance.

Authors:  J J Grygiel; L M Wing; J Farkas; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1979-11       Impact factor: 6.875

9.  Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems.

Authors:  G J Mannering; K W Renton; R el Azhary; L B Deloria
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

10.  Altered theophylline pharmacokinetics during acute respiratory viral illness.

Authors:  K C Chang; T D Bell; B A Lauer; H Chai
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

View more
  14 in total

Review 1.  The role of pharmacokinetics in the development of biotechnologically derived agents.

Authors:  R J Wills; B L Ferraiolo
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis C.

Authors:  Samir K Gupta; Karen Kolz; David L Cutler
Journal:  Eur J Clin Pharmacol       Date:  2010-12-16       Impact factor: 2.953

Review 3.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

5.  Use of modelling and simulation techniques to support decision making on the progression of PF-04878691, a TLR7 agonist being developed for hepatitis C.

Authors:  Hannah M Jones; Phylinda L S Chan; Piet H van der Graaf; Robert Webster
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

6.  A pharmacokinetic and pharmacodynamic comparison of a novel pegylated recombinant consensus interferon-α variant with peginterferon-α-2a in healthy subjects.

Authors:  Li Zheng; Mao Ping Li; Zhong Ping Gou; Ying Wang; Nan Xu; Yong Ming Cai; Hua Luo
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

Review 7.  CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications.

Authors:  Jang-Ik Lee; Lei Zhang; Angela Y Men; Leslie A Kenna; Shiew-Mei Huang
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

Review 8.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

9.  Effects of lansoprazole on pharmacokinetics and metabolism of theophylline.

Authors:  T Kokufu; N Ihara; N Sugioka; H Koyama; T Ohta; S Mori; K Nakajima
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 10.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.